<DOC>
	<DOCNO>NCT00002329</DOCNO>
	<brief_summary>To characterize safety profile MDL 28574A follow acute subchronic dose HIV-positive patient . To determine MTD acute subchronic dos drug administer oral solution . To determine pharmacokinetic profile MDL 28574A castanospermine ( MDL 28574A derive ) follow acute subchronic dosing .</brief_summary>
	<brief_title>A Study MDL 28,574A HIV-Infected Patients</brief_title>
	<detailed_description>In Part A study , patient receive single oral dose MDL 28574A day 1 follow day 7 . In Part B , patient receive single daily dos drug day 1 14 follow day 21 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4 count &gt; = 500 cells/mm3 . No evidence AIDS . No antiretroviral therapy within 30 day prior study entry . NOTE : Presence lymphadenopathy two extrainguinal site , least 1 cm diameter 3 month , permit . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Clinically significant abnormality routine hematology ( CD4 count Western blot ) , serum chemistry , urinalysis . Abnormal EKG . Positive stool guaiac . Abnormal medical history physical exam include temperature , heart rate , blood pressure . Clinically significant organ abnormality disease . Positive urine drug screen illicit drug . Inability comply study procedure . Concurrent Medication : Excluded : Routine treatment nonprescription medication . Treatment medication except approval investigator . Patients follow prior condition exclude : Prior participation trial . Serious physical mental illness within 1 year prior study entry would confound interpretation data . Prior Medication : Excluded : Antiretroviral therapy within 30 day prior study entry . Known medication alter renal , hepatic , hematologic/immunologic function ( barbiturate , phenothiazine , cimetidine , immunomodulators ) within 14 day prior study entry . Routine treatment nonprescription medication within 3 day prior study entry . History alcohol drug abuse within past year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 1995</verification_date>
	<keyword>MDL 28574</keyword>
</DOC>